Trial Profile

Multicenter study phase IIb randomized, blind, controlled with Placebo in search of doses to assess efficacy, safety and tolerability of two dose Subcutaneas IPP-201101 more medication of base, versus Placebo more basic medication in patients with Systemic Lupus Erythematosus (SLE).

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 02 Aug 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

28 Jan 2013 Results have been published in Annals of the Rheumatic Diseases according to an ImmuPharma media release.
14 Nov 2012 Results presented at the 76th Annual Scientific Meeting of the American College of Rheumatology and the 47th Annual Meeting of the Association of Rheumatology and Health Professionals.
14 Nov 2012 Status changed from recruiting to completed.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com